UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: April 24, 2024
Accession Number: 0001213900-24-034613
Submission Type: POS AM
CIK: 0001690080
Company Name: 180 Life Sciences Corp.
File Number: 333-276796